Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study.

Crater, Glenn D; Lalonde, Karine; Ravenelle, François; Harvey, Michael; Després, Jean-Pierre.

Diabetes Obes Metab ; 26(2): 642-649, 2024 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-37941317

2.

Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis.

Donohue, James F; Kerwin, Edward; Barnes, Chris N; Moran, Edmund J; Haumann, Brett; Crater, Glenn D.

BMC Pulm Med ; 20(1): 134, 2020 May 11.

Artículo en Inglés | MEDLINE | ID: mdl-32393215

3.

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19.

Singh, Dave; Bogus, Maxim; Moskalenko, Valentyn; Lord, Robert; Moran, Edmund J; Crater, Glenn D; Bourdet, David L; Pfeifer, Nathan D; Woo, Jacky; Kaufman, Elad; Lombardi, David A; Weng, Emily Y; Nguyen, Tuan; Woodcock, Ashley; Haumann, Brett; Saggar, Rajeev.

Eur Respir J ; 58(4)2021 10.

Artículo en Inglés | MEDLINE | ID: mdl-34210790

4.

Fluticasone propionate/salmeterol 250/50 µg versus salmeterol 50 µg after chronic obstructive pulmonary disease exacerbation.

Ohar, Jill A; Crater, Glenn D; Emmett, Amanda; Ferro, Thomas J; Morris, Andrea N; Raphiou, Ibrahim; Sriram, Peruvemba S; Dransfield, Mark T.

Respir Res ; 15: 105, 2014 Sep 24.

Artículo en Inglés | MEDLINE | ID: mdl-25248764

5.

Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.

Ohar, Jill A; Mahler, Donald A; Davis, Gabrielle N; Lombardi, David A; Moran, Edmund J; Crater, Glenn D.

Can Respir J ; 2024: 8034923, 2024.

Artículo en Inglés | MEDLINE | ID: mdl-38560416

6.

Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD.

Dalal, Anand A; Shah, Manan B; D'Souza, Anna O; Lunacsek, Orsolya E; Nagar, Saurabh P; Crater, Glenn D.

Respir Res ; 13: 41, 2012 May 31.

Artículo en Inglés | MEDLINE | ID: mdl-22651541

7.

Lung deposition of inhaled once-daily long-acting muscarinic antagonists via standard jet nebulizer or dry powder inhaler, measured using functional respiratory imaging, in patients with chronic obstructive pulmonary disease.

Crater, Glenn D; Johnson, Karmon; Ward, Jonathan; Backer, Jan De.

Ther Adv Respir Dis ; 16: 17534666221077561, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-35234085

8.

Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Randomized, 42-Day Study.

Siler, Thomas M; Moran, Edmund J; Barnes, Chris N; Crater, Glenn D.

Chronic Obstr Pulm Dis ; 7(2): 99-106, 2020 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-32324981

9.

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials.

Sethi, Sanjay; Donohue, James F; Ferguson, Gary T; Barnes, Chris N; Crater, Glenn D.

Ther Adv Respir Dis ; 14: 1753466620905278, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-32106777

10.

Peak Inspiratory Flows: Defining Repeatability Limits and a Predictive Equation for Different Inhalers.

Barnes, Chris N; Mahler, Donald A; Ohar, Jill A; Lombardi, David A; Crater, Glenn D.

Chest ; 158(4): 1413-1419, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32343967

11.

Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate.

Mahler, Donald A; Ohar, Jill A; Barnes, Chris N; Moran, Edmund J; Pendyala, Srikanth; Crater, Glenn D.

Chronic Obstr Pulm Dis ; 6(4)2019 Oct 23.

Artículo en Inglés | MEDLINE | ID: mdl-31647854

12.

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.

Maltais, François; Mahler, Donald A; Pepin, Véronique; Nadreau, Eric; Crater, Glenn D; Morris, Andrea N; Emmett, Amanda H; Ferro, Thomas J.

Eur Respir J ; 42(2): 539-41, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23904549

13.

Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy.

Dalal, Anand A; Shah, Manan; D'Souza, Anna O; Crater, Glenn D.

Respir Med ; 106(6): 829-37, 2012 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-22425138

14.

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial.

Kelleher, Dennis L; Mehta, Rashmi S; Jean-Francois, Bernadette M; Preece, Andrew F; Blowers, James; Crater, Glenn D; Thomas, Paul.

PLoS One ; 7(12): e50716, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-23284643

15.

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.

Hanania, Nicola A; Crater, Glenn D; Morris, Andrea N; Emmett, Amanda H; O'Dell, Dianne M; Niewoehner, Dennis E.

Respir Med ; 106(1): 91-101, 2012 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-22040533

16.

Outcomes associated with timing of maintenance treatment for COPD exacerbation.

Dalal, Anand A; Shah, Manan B; D'Souza, Anna O; Dhamane, Amol D; Crater, Glenn D.

Am J Manag Care ; 18(9): e338-45, 2012 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-23009332

17.

Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD.

Dransfield, Mark T; Cockcroft, John R; Townsend, Raymond R; Coxson, Harvey O; Sharma, Sanjay S; Rubin, David B; Emmett, Amanda H; Cicale, Michael J; Crater, Glenn D; Martinez, Fernando J.

Respir Med ; 105(9): 1322-30, 2011 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-21696934

18.

Prevalence of airway obstruction assessed by lung function questionnaire.

Mintz, Matthew L; Yawn, Barbara P; Mannino, David M; Donohue, James F; Hanania, Nicola A; Grellet, Catherine A; Gilsenan, Alicia W; McLeod, Lori D; Dalal, Anand A; Raphiou, Ibrahim H; Prillaman, Barbara A; Crater, Glenn D; Cicale, Michael J; Mapel, Douglas W.

Mayo Clin Proc ; 86(5): 375-81, 2011 May.

Artículo en Inglés | MEDLINE | ID: mdl-21531880

19.

Safety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary disease.

Koser, Andras; Westerman, Jan; Sharma, Sanjay; Emmett, Amanda; Crater, Glenn D.

Open Respir Med J ; 4: 86-91, 2010 Oct 21.

Artículo en Inglés | MEDLINE | ID: mdl-21253451

20.

Levalbuterol vs racemic albuterol: science or drug company propaganda?

Crater, Glenn D.

Chest ; 124(3): 1175-6; author reply 1176-8, 2003 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-12970056

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: